Profilo
Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.
Precedenti posizioni note di Richard Schwartz
| Società | Posizione | Fine |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | 01/05/2008 |
Vaccine Research Center | Corporate Officer/Principal | - |
| VAXART, INC. | Direttore Tecnico/Scientifico/R&S | - |
| SYNLOGIC, INC. | Corporate Officer/Principal | - |
Formazione di Richard Schwartz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaccine Research Center | |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Synlogic, Inc.
Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
















